Yanuki
Finance / Healthcare
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will participate in Citi’s 2025 Global Healthcare Conference on December 3, 2025. CFO Charlie Wagner and CSO David Altshuler will engage in a fireside chat at 9:00 a.m. ET. A live webcast w...
News / Partnerships
Monumental Sports & Entertainment (MSE) has announced Vanda Pharmaceuticals as a Founding Partner for Capital One Arena. This multi-year agreement includes naming rights for the Monumental Sports Network (MNMT) broadcast studio and extensiv...
Health / Infectious Diseases
Tonix Pharmaceuticals has licensed TNX-4800, a monoclonal antibody, from UMass Chan Medical School for the prevention of Lyme disease. This single-dose prophylactic aims to provide seasonal protection against the disease.
Health / Mental Health
AbbVie (NYSE: ABBV) has acquired Gilgamesh Pharmaceuticals' Bretisilocin, a novel investigational therapy for major depressive disorder (MDD), for up to $1.2 billion. This acquisition significantly expands AbbVie's psychiatry pipeline and u...
Money / Markets
Vertex Pharmaceuticals (NASDAQ:VRTX) is preparing to announce its latest earnings. Investors are keen to understand how the stock will react, considering its historical performance and recent financial results.
Finance / Earnings
Vertex Pharmaceuticals (VRTX) reported a 12% increase in total revenue for the second quarter of 2025, reaching $2.96 billion. This growth was fueled by strong performance in cystic fibrosis (CF) therapies and the successful launches of new...
Markets / Tariffs
President Trump has announced proposals for new tariffs on copper and pharmaceuticals, potentially reshaping the trade landscape. These measures could significantly impact various industries and consumer prices.
Finance / Biotech
Vanda Pharmaceuticals Inc. (VNDA) is set to participate in the Mizuho Neuro & Ophthalmology Summit 2025 in New York City on May 21, 2025. This event provides an opportunity for Vanda to engage with investors and discuss advancements in neur...
Business / Pharmaceuticals
Roche, a Swiss pharmaceutical giant, is investing $50 billion in the United States over the next five years to expand its research, development, and manufacturing capabilities. This significant investment aims to create over 12,000 new jobs...
Finance / Stocks
Bayer AG's stock has shown minor gains recently, but the broader picture reveals significant pressure. This article recaps the latest performance data, financial results, and analyst outlooks compiled by Yanuki using the latest trends and d...
Finance / Biotech Stocks
Recursion Pharmaceuticals (often associated with the ticker RXRX) has announced a significant step in its clinical development pipeline: the first patient has been dosed in its early-stage clinical trial targeting B-cell lymphomas. This mil...
